Gerrit Meijer is a professor of pathology with a special interest in gastrointestinal oncology and translational research. After finishing medical school at the Vrije Universiteit Amsterdam he completed his PhD on “Cancer Risk Assessment in Adenoma Bearing Patients”. He had his training in pathology at the VU University Medical Center (VUmc) where he continued to work as a pathologist and from 2009 as chair of the Department of Pathology.  In 2015 he moved to the Netherlands Cancer Institute/Antoni van Leeuwenhoek, where he now is head of research & innovation at the Department of Pathology and head of the Division of Diagnostic Translational Oncology. Professor Meijer leads a translational research group that focuses on gastrointestinal cancer, especially biomarker development for early detection of colorectal cancer, as well as on definition of molecular intermediate endpoints for screening. This work is amongst other funded by a Stand Up To Cancer & Dutch Cancer Society “Dream Team” grant for early detection of colorectal cancer. Next to that he is involved in the development of (inter-)national research infrastructures for biobanking and research IT, including TraIT, Health-RI, BBMRI, EATRIS, tranSMART foundation as well as AACR GENIE.Gerrit Meijer has been closely involved in the development, implementation and execution of the Dutch national colorectal cancer screening program, serving on several program committees.